Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 858.00
Bid: 834.00
Ask: 856.00
Change: 30.00 (3.62%)
Spread: 22.00 (2.638%)
Open: 840.00
High: 876.00
Low: 822.00
Prev. Close: 828.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

24 May 2023 07:00

RNS Number : 4155A
Mortgage Advice Bureau (Hldgs) PLC
24 May 2023
 

24 May 2023

Mortgage Advice Bureau (Holdings) plc ("MAB" or "the Group")

AGM Statement

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1.L) will hold its Annual General Meeting at 2pm today during which the Non-Executive Chair, Katherine Innes Ker, will make the following statement:

"In an ongoing challenging environment, we continue to demonstrate the strength of MAB's model and resilience in adviser numbers and mortgage completions against a significantly weaker market backdrop. This positions the Group well for subsequent market recovery.

"Our Adviser numbers have stabilised in Q2 at 2,1221 advisers on 19 May 2023. We expect our existing Appointed Representative firms to start growing their adviser numbers again later in the year, most likely as consumer confidence improves further when there is more certainty around the outlook for mortgage interest rates and our firms can plan with a greater degree of certainty. Our pipeline of incoming new Appointed Representatives has grown strongly this year.

"As expected, the value of completions in the wider market was slower in Q1 2023 with a 21% reduction in new mortgage lending2 compared to last year. MAB's total mortgage completions for Q1 2023 were broadly stable at £5.8bn (2022: £5.9bn). Our new mortgage completions were £4.4bn (2022: £4.9bn) with the balance of £1.4bn (2022: £1.0bn) being Product Transfers. We have continued to grow our market share, which has been achieved despite a reduction in the number of advisers since Q4 2022.

"During the six months following the mini-budget, new mortgage approvals across the market were down by as much as 40% versus the prior year. There are early signs of increasing activity and mortgage approval levels have now gradually started to improve, but remain significantly lower than for the equivalent period last year.

"MAB's performance, despite challenging market conditions, remains in line with the Board's expectations with further improvement expected in the second-half of the year."

 

1 Includes 139 Fluent advisers as at 19 May 2023 (76 advisers in the first charge mortgages division, 49 in the secured personal loans division, 8 in the later life division, and 6 in the bridging finance division). Includes a total of 183 advisers at 19 May 2023 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 UK Finance, product transfer lending figures not available until 7 June.

 

Enquiries:

Mortgage Advice Bureau (Holdings) Plc

Tel: +44 (0) 1332 525007

 

Peter Brodnicki - Chief Executive Officer

Ben Thompson - Deputy Chief Executive Officer

Lucy Tilley - Chief Financial Officer

 

Nominated Adviser and Joint Broker:

Numis Securities Limited

Stephen Westgate / Giles Rolls

 

+44 (0)20 7260 1000

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke

 

+44 (0) 20 7418 8900

Media Enquiries: investor.relations@mab.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEDFWDEDSEEI
Date   Source Headline
17th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20215:59 pmRNSDirectors' Shareholdings and PDMR notification
4th Aug 20212:36 pmRNSHolding(s) in Company
30th Jul 20211:12 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20217:00 amRNSTrading Update
14th Jul 20214:27 pmRNSDirectors' Shareholdings and PDMR notification
30th Jun 20214:13 pmRNSDirectors' Shareholdings and PDMR notification
22nd Jun 20212:23 pmRNSDirectors' Shareholdings and PDMR notification
15th Jun 202111:38 amRNSDirectors' Shareholdings and PDMR notification
11th Jun 20214:33 pmRNSPDMR dealing and Total Voting Rights
11th Jun 202111:53 amRNSBlock listing Interim Review
28th May 20215:00 pmRNSDirectors' Shareholdings and PDMR notification
25th May 20213:00 pmRNSResult of AGM
25th May 20217:00 amRNSAGM Statement
14th May 20211:40 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 202111:24 amRNSDirectors' Shareholdings and PDMR notification
20th Apr 20212:27 pmRNSPosting of Report and Accounts and Notice of AGM
15th Apr 20214:46 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Apr 20212:49 pmRNSGrant of Options and PDMR Dealing
1st Apr 20215:09 pmRNSHolding(s) in Company
31st Mar 202112:45 pmRNSDirector/PDMR Shareholding
30th Mar 202112:28 pmRNSHolding(s) in Company
29th Mar 20211:58 pmRNSPDMR dealing
29th Mar 202111:04 amRNSPlacing of Mortgage Advice Bureau Shares
24th Mar 20217:00 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20215:23 pmRNSDirector/PDMR Shareholding
8th Mar 20214:35 pmRNSPrice Monitoring Extension
26th Feb 20211:48 pmRNSDirector/PDMR Shareholding
15th Feb 20215:24 pmRNSDirector/PDMR Shareholding
8th Feb 20214:41 pmRNSSecond Price Monitoring Extn
8th Feb 20214:36 pmRNSPrice Monitoring Extension
29th Jan 202112:59 pmRNSDirector/PDMR Shareholding
20th Jan 20217:00 amRNSTrading Update and NED Appointment
8th Jan 20214:42 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 202112:49 pmRNSDirector/PDMR Shareholding
31st Dec 202012:00 pmRNSTotal Voting Rights
21st Dec 20204:41 pmRNSSecond Price Monitoring Extn
21st Dec 20204:36 pmRNSPrice Monitoring Extension
18th Dec 20205:13 pmRNSDirector/PDMR Shareholding
14th Dec 20204:40 pmRNSSecond Price Monitoring Extn
14th Dec 20204:35 pmRNSPrice Monitoring Extension
14th Dec 20203:38 pmRNSDirector/PDMR Shareholding
11th Dec 202011:30 amRNSBlock listing Interim Review
9th Dec 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20205:45 pmRNSDirector/PDMR Shareholding
30th Nov 202012:29 pmRNSTotal Voting Rights
23rd Nov 20208:30 amRNSHolding(s) in Company
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.